Christopher Ohl to Drug Therapy, Combination
This is a "connection" page, showing publications Christopher Ohl has written about Drug Therapy, Combination.
Connection Strength
0.216
-
Koliscak LP, Johnson JW, Beardsley JR, Miller DP, Williamson JC, Luther VP, Ohl CA. Optimizing empiric antibiotic therapy in patients with severe ß-lactam allergy. Antimicrob Agents Chemother. 2013 Dec; 57(12):5918-23.
Score: 0.106
-
Wrenn RH, Cluck D, Kennedy L, Ohl C, Williamson JC. Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia. J Oncol Pharm Pract. 2018 Apr; 24(3):170-175.
Score: 0.033
-
Liu P, Ohl C, Johnson J, Williamson J, Beardsley J, Luther V. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program. BMC Infect Dis. 2016 Dec 12; 16(1):751.
Score: 0.033
-
Rokas KE, Johnson JW, Beardsley JR, Ohl CA, Luther VP, Williamson JC. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection. Clin Infect Dis. 2015 Sep 15; 61(6):934-41.
Score: 0.030
-
Moyenuddin M, Ohl CA, Williamson JC, Peacock JE. Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy. J Antimicrob Chemother. 2003 Jan; 51(1):202-3.
Score: 0.013